TickerFacts.

Company research / BIOA

BioAge Labs, Inc. (BIOA)

Build a valuation ↗↓ Download CSV

CIK 0001709941 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, BioAge Labs, Inc. reported revenue of $8.99M. Over the twelve months to 2026-06-30, revenue was $10.36M.

Key ratios (year ended 2025-12-31)

n/m
Operating margin
-896.1%
Net margin
-29.6%
Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-31
Revenue$10.36M$8.99M$0n/a
R&D Expense$87.79M$73.97M$59.04M$33.89M
Operating Income-$106.27M-$92.78M-$78.19M-$48.40M
Net Income-$94.46M-$80.61M-$71.11M-$63.85M
EPS (Diluted)n/a-$2.24-$6.63-$38.17
Total Assets$396.93M$294.89M$358.23M$25.92M
Total Liabilities$22.02M$22.84M$35.11M$66.60M
Long-Term Debtn/an/a$8.50Mn/a
Shareholders' Equity$374.91M$272.05M$323.13M-$173.40M
Cash & Equivalents$73.96M$188.89M$354.35M$21.64M
Operating Cash Flow-$87.60M-$81.63M-$51.52M-$37.36M
Capital Expenditures$488.0K$719.0K$366.0K$166.0K
Free Cash Flow-$88.09M-$82.35M-$51.89M-$37.53M
Shares Outstanding45.78M37.39M35.85M1.67M
Weighted Average Diluted Sharesn/a35.93M10.73M1.67M
EPS (Basic)n/a-$2.24-$6.63-$38.17

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView